Impact of Epigenome-Wide Methylation and Breast Cancer Recurrence in Women Tested Negative for BRCA Genes: The Breast Methylation Risk (BREMERI) Study

Our exploratory study suggests that specific DNA methylation patterns in WBCs, particularly in genes related to cellular proliferation, invasion, and glucose homeostasis, may be associated with the risk of breast cancer recurrence in <i>BRCA</i> wild-type women. If validated in larger cohorts, these circulating signatures may serve as blood-based biomarkers to improve risk stratification and guide tailored treatment strategies.

Authors

Institutions

Publication Details

Journal
Cancers
Published
2025-09-26
DOI
https://doi.org/10.3390/cancers17193132
Citations
1
Primary Topic
Epigenetics and DNA Methylation
Type
article
Field-Weighted Citation Impact
0.81

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of Epigenome-Wide Methylation and Breast Cancer Recurrence in Women Tested Negative for BRCA Genes: The Breast Methylation Risk (BREMERI) Study

Debora Macis, Monica Marabelli, Mariarosaria Calvello, Sara Gandini et al.
1 citations
Cancers
Epigenetics and DNA Methylation
0.81
article

Impact of Epigenome-Wide Methylation and Breast Cancer Recurrence in Women Tested Negative for BRCA Genes: The Breast Methylation Risk (BREMERI) Study

Debora Macis, Monica Marabelli, Mariarosaria Calvello, Sara Gandini, Davide Serrano, Francesca Fava, Sara Cagnacci, Federica Bellerba, Silvia Polidoro, Irène Feroce, Valentina Aristarco, Harriet Johansson, Cristina Zanzottera, Aliana Guerrieri‐Gonzaga, Giovanni Cugliari, Bernardo Bonanni
article en
1 citations

Abstract

Our exploratory study suggests that specific DNA methylation patterns in WBCs, particularly in genes related to cellular proliferation, invasion, and glucose homeostasis, may be associated with the risk of breast cancer recurrence in <i>BRCA</i> wild-type women. If validated in larger cohorts, these circulating signatures may serve as blood-based biomarkers to improve risk stratification and guide tailored treatment strategies.

CancersVol. 17(19)
Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT), University of Turin (IT), European Institute of Oncology (IT)
Ministero della Salute
Openalex Percentile: Top 23%
Epigenetics and DNA Methylation
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Impact of Epigenome-Wide Methylation and Breast Cancer Recurrence in Women Tested Negative for BRCA Genes: The Breast Methylation Risk (BREMERI) Study — Debora Macis, Monica Marabelli, et al. · Cancers (2025) | TGRS Research Map | TGRS